Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Pancreatic Ductal Adenocarcinoma (PDAC)
View Full LandscapeTarget Indication
Pancreatic Ductal Adenocarcinoma (PDAC)
Clinical Trial
NCT07450859Last updated: 4/23/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Urinary Bladder Neoplasm
Metastatic Urothelial Cancer
Non-Small Cell Lung Cancer
Advanced Solid Tumor Historically Known for High EphA2 Expression
Advanced Solid Tumor